Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma
Figure 3
(a) The anti-CCNY antibody level was detected by ELISA for serum samples from each group. (b) An ROC analysis of serum anti-CCNY antibody levels in no small cell lung cancer patients versus healthy controls.
